NCT03301766

Adjunctive 5% Lidocaine Patches for Acute Non-radicular Low Back Pain in Emergency Department Patients

Adjunctive 5% Lidocaine Patches in the Treatment of Acute Non-radicular Low Back Pain in Patients Discharged From the Emergency Department

• Status: Withdrawn
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: Cook County Health · Other Government
• Sex: All
• Age: 24 Years – 64 Years
• Healthy volunteers: Not accepted

Summary

This study will evaluate the addition of lidocaine % transdermal patches to standard therapy in the treatment of acute non-radicular low back pain in patients discharged from the Emergency Department. In addition to standard therapy, half of the participants will receive medicated patches while the other half will receive non-medicated patches.

Detailed description

Low back pain is a common emergency department (ED) chief complaint. Multiple therapies have been evaluated in the treatment of ED patients with low back pain including acetaminophen, NSAIDS, opioids, steroids, and muscle relaxants. Lidocaine is a local anesthetic that can be administered by various routes. It is used in a transdermal patch for the treatment of pain. It is commonly used for focal causes of pain, including low back pain. The addition of lidocaine 5% patches to standard low back pain therapy has not been rigorously evaluated, although it is frequently used.

Conditions

• Low Back Pain

Interventions

Type	Name	Description
DRUG	lidocaine 5% patch	transdermal patch
DRUG	standard therapy	Drugs prescribed at the discretion of the treating physician (acetaminophen, NSAIDs, muscle relaxants, etc)
DRUG	Non-medicated patch	non-medicated patch

Timeline

• Start date: 2017-03-10
• Primary completion: 2023-05-22
• Completion: 2023-05-22
• First posted: 2017-10-04
• Last updated: 2023-06-29

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study